Search

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO COMMENTS ON OBJECTIVES FOR U.S. JAPAN TRADE AGREEMENT

BIO supports the U.S. Trade Representative's negotiations with the Government of Japan as an opportunity to grow U.S. exports and create...

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies

COMPANIES TRACKING MUTATIONS IN CANCER CELLS CAN PROVIDE A KEY TO UNLOCKING BETTER THERAPIES

Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through...

 
 
 
Inside Front Cover: Biotechnology Journal 12/2018

INSIDE FRONT COVER: BIOTECHNOLOGY JOURNAL 12/2018

The description of our cover and the work it represents is as follows: A bacterial P450 is artificially‐assembled with multiple ferredoxin...

Inside Back Cover: Biotechnology Journal 12/2018

INSIDE BACK COVER: BIOTECHNOLOGY JOURNAL 12/2018

Four‐dimensional bioprinting has emerged taking into account conformational changes that can occur in printed structures employing...

 
 
 
Cover Picture: Biotechnology Journal 12/2018

COVER PICTURE: BIOTECHNOLOGY JOURNAL 12/2018

Lipid tubules are of particular interest for many potential applications in nanotechnology. Among various techniques for the material...

PLANTS AS ANTIFUNGAL FACTORIES

Researchers have developed a biotechnological tool to produce, in a very efficient manner, antifungal proteins in the leaves of the...

 
 
 

PREDICTING STRAIN ENGINEERING STRATEGIES USING IKS1317: A GENOME‐SCALE METABOLIC MODEL OF STREPTOMYCES COELICOLOR

Abstract Streptomyces coelicolor is a model organism for the Actinobacteria, a phylum known to produce an extensive range of different...

Brii Bio's Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline

BRII BIO'S ALLIANCE WITH VBI VACCINES ADDS HEPATITIS B DRUG TO PIPELINE

Brii Biosciences launched earlier this year with $260 million and a mission to find new medicines in infectious disease and other therapeutic...

 
 
 

AMGEN ANNOUNCES FIRST-IN-HUMAN DATA EVALUATING INVESTIGATIONAL NOVEL BITE® IMMUNOTHERAPIES AMG 420 AND AMG 330 AT ASH 2018

Phase 1 Results of Amgen's BiTE® Platform in Heavily Pre-Treated Patients With Multiple Myeloma and Acute Myeloid LeukemiaFDA Grants...

 
 
 

CAR T-CELL THERAPIES SHOW DURABLE RESPONSES, NEW RESEARCH ALSO EXPLORES COMBINATION THERAPIES TO EXTEND AND ENHANCE TREATMENT RESPONSES

SAN DIEGO, Dec. 3, 2018 /PRNewswire/ - Chimeric antigen receptor T-cell therapies have quickly shifted the treatment paradigm for many...

CRISPR BABIES RAISE AN UNCOMFORTABLE REALITY - ABIDING BY SCIENTIFIC STANDARDS DOESN'T GUARANTEE ETHICAL RESEARCH

Uncertainty continues to swirl around scientist He Jiankui's gene editing experiment in China. Using CRISPR technology, He modified...

 
 
 

STUDY PUBLISHED IN NATURE BIOMED SHOWS PROMISE FOR PATIENTS WITH NEUROLOGICAL CONDITIONS INCLUDING PARKINSON'S DISEASE, DEPRESSION AND EPILEPSY

Study Demonstrates Targeted Muscle Movement Through Brain Stimulation Without Open Brain Surgery NEW YORK and SAN FRANCISCO, Dec. 3,...

KNOWING EXACTLY WHAT GENES ARE SAYING - AND WHERE

Scientists can now discover how the fine details of gene activity differ from one cell type to another in a tissue sample, thanks to...

 
 
 

INACTIVATING GENES CAN BOOST CROP GENETIC DIVERSITY

Researchers from CIRAD and INRA recently showed that inactivating a gene, RECQ4, leads to a three-fold increase in recombination in...

THIS ISSUE HAS A LOT GOING ON & MOVING ON

Biotechnology Progress, EarlyView.

 
 
 

VIR STARTS TRIAL OF RNAI DRUG FOR HEP B SEEKING FUNCTIONAL CURE

Vir Biotechnology has started a phase 1/2 trial of its gene-silencing drug for hepatitis B virus, the first clinical candidate from...

IS THE FUTURE OF DOG HEALTH IN A DNA TEST?

Information from commercial DNA tests helped reveal the genetic origins of the husky's captivating blue eyes and may even help us treat...

 
 
 

NEW TRICKS OF TALES: DISCOVERY OF A NEW PRINCIPLE OF GENE REGULATION BY MOLECULAR DISPLACEMENT

Transcription activator-like effector proteins can be designed to bind to almost any selected DNA. Researchers now report that a TALE...

STRATEGIES FOR HUMANIZING GLYCOSYLATION PATHWAYS AND PRODUCING RECOMBINANT GLYCOPROTEINS IN MICROBIAL EXPRESSION

Homogeneously glycosylated proteins are essential for analyzing the structure of N‐glycans, studying their consequences inside cells,...